LCL161 is a SMAC mimetic, an IAP antagonist with oral activity that inhibits XIAP (IC50=35 nM) in HEK293 cells and also inhibits cIAP1 (IC50=0.4 nM) in MDA-MB-231 cells. LCL161 has potential antitumor activity.
Molecular Weight:
500.63
Purity:
98.00%
CAS Number:
[1005342-46-0]
Formula:
C26H33FN4O3S
Target:
IAP
T2080
T2080
* VAT and and shipping costs not included. Errors and price changes excepted